Alpha Cognition Inc. (ACOG) vs Oramed Pharmaceuticals Inc. (ORMP)

Alpha Cognition Inc. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Alpha Cognition Inc. and Oramed Pharmaceuticals Inc. are of similar size ($184.0M and $173.9M). Alpha Cognition Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.0×. Oramed Pharmaceuticals Inc. has the higher net margin (0.00% vs −137.7%) and the higher return on invested capital (−3.40% vs −144.7%). Across the 15 metrics below, Oramed Pharmaceuticals Inc. leads on 10 and Alpha Cognition Inc. on 5.

Valuation

Metric ACOG ORMP Biotechnology median
P/E n/m 0.96 8.50
P/S 11.69 41.54 9.71
P/B 3.37 0.53 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 9.04 28.95 9.21
Earnings yield (13.19%) 103.93% (33.15%)
Free cash flow yield (20.79%) (3.12%) (25.50%)

Profitability

Metric ACOG ORMP Biotechnology median
Gross margin 90.37% 32.31% 65.16%
Operating margin (174.70%) 0.00% 0.00%
Net margin (137.69%) 0.00% 0.00%
Free cash flow margin (242.99%) 0.00% 0.00%
Return on equity (49.53%) 73.90% (56.36%)
Return on assets (38.33%) 65.52% (48.04%)
Return on invested capital (144.65%) (3.40%) 0.00%

Growth

Metric ACOG ORMP Biotechnology median
Revenue growth (TTM) — 347.77% 6.02%
EPS growth (last fiscal year) 42.08% 412.50% 30.26%
Revenue growth, 5-year CAGR — (5.85%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG ORMP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 4.98 4.72
Net debt to EBITDA 2.92 8.41 0.96

Dividend

Metric ACOG ORMP Biotechnology median
Dividend yield — 6.14% 0.09%
Payout ratio — 0.06 —

Size

Metric ACOG ORMP Biotechnology median
Market cap 184.02m 173.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack